GlassScriptPhysician profile
Mark G Davies
NPI 1477581619
$10,052.47
in general payments reported to CMS, 2019-2025
37 companies · $1,837 in 2025
The $1,837 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $549 · 2020: $3,098 · 2021: $1,392 · 2022: $1,012 · 2023: $1,226 · 2024: $938 · 2025: $1,837.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,405 · Travel and Lodging: $596.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,404.99 |
| Travel and Lodging | $596.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $2,383.33 | 2020 | |
| W. L. Gore & Associates, INC. | $1,391.86 | 2020-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Viabahn Endoprosthesis With Heparin, Gore Viabahn Vbx Balloon Expandable Endo |
| Bard Peripheral Vascular, INC. | $1,287.74 | 2020-2025 | Lutonix Drug Coated Balloon, Fluency Endovascular Stent Graft, Rotarexs 6 F X 135 Cm |
| Medtronic, INC. | $866.83 | 2021-2025 | Hawkone, Endurant Iis, Concertotm |
| Silk Road Medical, INC. | $618.91 | 2023-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Endologix LLC | $436.84 | 2025 | Alto Abdominal Stent Graft System |
| Medtronic Vascular, INC. | $425.63 | 2019-2020 | |
| Cvrx, INC. | $274.95 | 2021-2023 | Barostim Neo System |
| Penumbra, INC. | $267.42 | 2022-2023 | Indigo System |
| Cook Medical LLC | $252.75 | 2019-2023 | Rosen |
| Organogenesis INC. | $170.48 | 2021-2023 | Puraply |
| Smith+Nephew, INC. | $156.42 | 2021-2022 | |
| Cardiva Medical, INC. | $152.51 | 2022-2023 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Vvcs 6-12f |
| Mylan Specialty L.P. | $119.78 | 2019 | |
| Boston Scientific Corporation | $116.24 | 2019-2025 | Eluvia |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| La Jolla Pharmaceutical Company | $114.99 | 2021 | |
| Portola Pharmaceuticals, LLC | $113.88 | 2019 | |
| Angiodynamics, INC. | $109.27 | 2020 | |
| Horizon Therapeutics Plc | $90.56 | 2022 | |
| Abbvie INC. | $84.47 | 2022-2023 | Dalvance |
| Surmodics, INC. | $82.84 | 2023 | Pounce Venous Thrombectomy System, Sublime Radial Access Guide Sheath, Pounce Thrombectomy |
| Shockwave Medical, INC | $61.25 | 2025 | |
| Abbott Laboratories | $52.64 | 2025 | Eterna |
| Kerecis Limited | $52.39 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Tactile Systems Technology INC | $48.67 | 2024-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Inspiremd LTD | $45.99 | 2025 | Cguard Prime Carotid Stent System |
| Lemaitre Vascular, INC. | $44.74 | 2024-2025 | Artegraft Vascular Graft, Pruitt F3 Carotid Shunt |
| Stryker Corporation | $40.58 | 2025 | Flowtriever |
| Integra Lifesciences Corporation | $37.25 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Acera Surgical, INC. | $33.94 | 2020-2022 | |
| Solventum Corporation | $27.60 | 2025 | Prevena, V.A.C.Ulta, V.A.C. Veraflo Cleanse Choice |
| Cardiovascular Systems INC. | $22.33 | 2020 | |
| Bolton Medical INC | $21.25 | 2019 | |
| Teleflex LLC | $18.20 | 2023 | Manta |
| Philips North America LLC | $14.64 | 2020 | |
| Pfizer INC. | $13.30 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Davies listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.